2022 Annual Meeting | C121 - Neurologic Consultations in Cancer Patients

Date Wednesday 04/06/22

Time 07:00 AM - 09:00 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Roy E. Strowd III, MD, FAAN

Topic(s) Neuro-oncology

Learning Objectives Participants will identify the common and rare long-term neurological complications that occur in patients with a systemic malignancy including posterior reversible encephalopathy, progressive multifocal leukoencephalopathy, leptomeningeal metastasis, and chemotherapy induced peripheral neuropathy; Describe the work up and approach to managing long-term survivors of brain cancer who present with new neurological deficit including post-treatment vasculopathy, myelopathy, or radiation induced malignancy

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based

Program Materials Program Evaluations

Event Timeline
07:00 AM - 07:05 AM PDT	Introduction	Introduction Roy E. Strowd III, MD, FAAN
07:00 AM - 07:00 AM PDT	Speaker	Walk-in Slides Roy E. Strowd III, MD, FAAN
07:05 AM - 07:45 AM PDT	Speaker	Common Calls from the Cancer Center: Neurological Symptoms in Patients with Systemic Malignancy Amy A. Pruitt, MD, FAAN
07:45 AM - 08:25 AM PDT	Speaker	From Horses to Zebras: Neurological Syndromes in Late Survivors of Primary Brain Tumors Alyx B. Porter, MD, FAAN
08:25 AM - 08:55 AM PDT	Discussion	Clinical Cases: Review of Neurological Complications in Cancer Patient Cases Roy E. Strowd III, MD, FAAN
08:55 AM - 09:00 AM PDT	Closing Remarks	Conclusion Roy E. Strowd III, MD, FAAN

Faculty Disclosures
Amy A. Pruitt, MD, FAAN	Dr. Pruitt has nothing to disclose.
Alyx B. Porter, MD, FAAN	Dr. Porter has a non-compensated relationship as a Board Member with American Brain Foundation that is relevant to AAN interests or activities.
Roy E. Strowd III, MD, FAAN	Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ��ɫ��. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.

��ɫ����

��ɫ����

��ɫ��

��ɫ��